New hope for leukemia patients who have run out of options
NCT ID NCT07245251
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early study tests a new drug called STR-P004 in 11 adults with a type of leukemia (ALL) that has come back or not responded to standard treatments. The main goals are to check if the drug is safe, find the right dose, and see if it helps fight the cancer. Participants will receive multiple doses and be closely monitored.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBKASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- TikTok meets oncology: can influencer videos boost chemo adherence in teens?
- New CAR-T therapy aims to tackle tough blood cancers
- New 'Sandwich' strategy aims to stop leukemia relapse after CAR-T
- Real-World data sought on Ponatinib's impact against rare leukemia
- New hope for older leukemia patients: gentler chemo shows promise
- Which exercise helps kids bounce back after leukemia? new study tests two approaches